BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31933576)

  • 1. Expression of the
    Abusibaa WA; Srour MA; Moslemi AR; Svensson L; Jesus C; Mendes F; Hesse C
    Transfus Med Hemother; 2019 Dec; 46(6):450-454. PubMed ID: 31933576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GBGT1 is allelically diverse but dispensable in humans and naturally occurring anti-FORS1 shows an ABO-restricted pattern.
    Hult AK; McSherry E; Möller M; Olsson ML
    Transfusion; 2018 Aug; 58(8):2036-2045. PubMed ID: 30277576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between ABO and Forssman (FORS) blood group systems: FORS1 antigen synthesis by ABO gene-encoded glycosyltransferases.
    Yamamoto M; Cid E; Yamamoto F
    Sci Rep; 2017 Jan; 7():41632. PubMed ID: 28134301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO blood group A transferases catalyze the biosynthesis of FORS blood group FORS1 antigen upon deletion of exon 3 or 4.
    Yamamoto M; Cid E; Yamamoto F
    Blood Adv; 2017 Dec; 1(27):2756-2766. PubMed ID: 29296927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal anti-A activity against the FORS1 (Forssman) antigen.
    Barr K; Korchagina E; Popova I; Bovin N; Henry S
    Transfusion; 2015 Jan; 55(1):129-36. PubMed ID: 25039359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood group
    Cid E; Yamamoto M; Yamamoto F
    Blood Adv; 2018 Jun; 2(12):1371-1381. PubMed ID: 29898878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FORSCells: 40-days fixed prepared reagent for detection of anti-Forssman in humans.
    Ferreira S; Mourato C; Corpuz A; Galvão S; Hesse C; Rocha C; Jesus C; Mendes F
    J Immunol Methods; 2020 Mar; 478():112722. PubMed ID: 31816281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO blood group A transferase and its codon 69 substitution enzymes synthesize FORS1 antigen of FORS blood group system.
    Yamamoto M; Tarasco MC; Cid E; Kobayashi H; Yamamoto F
    Sci Rep; 2019 Jul; 9(1):9717. PubMed ID: 31273262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. May the FORS be with you: a system sequel.
    Hult AK; Olsson ML
    Immunohematology; 2020 Jan; 36(1):14-18. PubMed ID: 32324040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic basis of the human Forssman glycolipid antigen negativity.
    Yamamoto M; Cid E; Yamamoto F
    Sci Rep; 2012; 2():975. PubMed ID: 23240079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of sheep erythrocyte glycosphingolipids recognized by human anti-Forssman antibodies.
    Santos L; Jin C; Mourato C; Mendes F; Hesse C; Teneberg S
    Glycobiology; 2020 Oct; 30(11):881-894. PubMed ID: 32280958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FORS awakens: review of a blood group system reborn.
    Hult AK; Olsson ML
    Immunohematology; 2017 Jun; 33(2):64-72. PubMed ID: 28657765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells.
    Jacob F; Hitchins MP; Fedier A; Brennan K; Nixdorf S; Hacker NF; Ward R; Heinzelmann-Schwarz VA
    BMC Mol Biol; 2014 Oct; 15():24. PubMed ID: 25294702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antibodies to a new histo-blood system: the FORS system.
    Jesus C; Hesse C; Rocha C; Osório N; Valado A; Caseiro A; Gabriel A; Svensson L; Moslemi AR; Siba WA; Srour MA; Pereira C; Tomaz J; Teixeira P; Mendes F
    Blood Transfus; 2018 Feb; 16(2):178-183. PubMed ID: 27893352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo-blood group system.
    Svensson L; Hult AK; Stamps R; Ångström J; Teneberg S; Storry JR; Jørgensen R; Rydberg L; Henry SM; Olsson ML
    Blood; 2013 Feb; 121(8):1459-68. PubMed ID: 23255552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Usefulness of Rare Blood Group Systems in the Risk Determination for Severe COVID-19.
    Konstantinidis TG; Iliadi V; Martinis G; Panopoulou M
    Pathophysiology; 2021 Nov; 28(4):496-500. PubMed ID: 35366247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duffy blood group phenotype-genotype correlations using high-resolution melting analysis PCR and microarray reveal complex cases including a new null FY*A allele: the role for sequencing in genotyping algorithms.
    Lopez GH; Morrison J; Condon JA; Wilson B; Martin JR; Liew YW; Flower RL; Hyland CA
    Vox Sang; 2015 Oct; 109(3):296-303. PubMed ID: 25900316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCB1 C3435T and CYP2C19*2 polymorphisms in a Palestinian and Turkish population: A pharmacogenetic perspective to clopidogrel.
    Nassar S; Amro O; Abu-Rmaileh H; Alshaer I; Korachi M; Ayesh S
    Meta Gene; 2014 Dec; 2():314-9. PubMed ID: 25606414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO maternal-child discordance: Evidence of variable allelic expression and considerations for investigation.
    McKnight TFP; Strain JE; Vege S; Lam C; Hubbard EM; Kopko PM; Westhoff CM; Allen ES
    Transfusion; 2021 Mar; 61(3):979-985. PubMed ID: 33475168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Tri-allelic Single Nucleotide Polymorphisms of
    Yang S; Shi H; Zhang Z; Chen Z; Yang W; Zhu W
    Genet Test Mol Biomarkers; 2022 Jan; 26(1):43-48. PubMed ID: 35089072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.